Clarivate Plc (NYSE:CLVT) Shares Purchased by Xponance Inc.

Xponance Inc. raised its holdings in Clarivate Plc (NYSE:CLVT) by 17.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 18,222 shares of the company’s stock after acquiring an additional 2,689 shares during the period. Xponance Inc.’s holdings in Clarivate were worth $93,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Raymond James Financial Inc. acquired a new position in Clarivate in the fourth quarter valued at $19,172,000. Perpetual Ltd grew its holdings in Clarivate by 24.6% in the 4th quarter. Perpetual Ltd now owns 9,192,680 shares of the company’s stock valued at $46,699,000 after buying an additional 1,816,936 shares during the period. Thompson Siegel & Walmsley LLC boosted its position in shares of Clarivate by 14.4% in the fourth quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company’s stock worth $53,333,000 after acquiring an additional 1,323,329 shares during the last quarter. Geode Capital Management LLC grew its holdings in Clarivate by 8.6% in the third quarter. Geode Capital Management LLC now owns 7,243,336 shares of the company’s stock valued at $51,443,000 after purchasing an additional 571,289 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Clarivate by 112.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,040,426 shares of the company’s stock valued at $7,387,000 after purchasing an additional 551,838 shares during the period. Hedge funds and other institutional investors own 85.72% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reiterated a “sector perform” rating and issued a $6.00 price target on shares of Clarivate in a report on Thursday, February 20th.

Clarivate Price Performance

CLVT opened at $3.97 on Friday. Clarivate Plc has a 52-week low of $3.90 and a 52-week high of $7.77. The company has a 50 day moving average of $4.68 and a two-hundred day moving average of $5.42. The company has a market cap of $2.73 billion, a P/E ratio of -4.13 and a beta of 1.28. The company has a quick ratio of 0.88, a current ratio of 0.87 and a debt-to-equity ratio of 0.88.

Clarivate declared that its board has approved a stock repurchase plan on Monday, December 16th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 12.8% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.